Sonoma BioTherapeutics
sonomabio.comLocations
South San Francisco, CA, USA
industry
Biotechnology · DeepTech · Health
Size
51-200 employees
Stage
Other
founded in
2020
Sonoma Biotherapeutics is a clinical-stage biotechnology company focused on developing engineered regulatory T cell (Treg) therapies to treat serious autoimmune and inflammatory diseases. Founded by pioneers in Treg biology and cell therapy, the company employs proprietary platform technologies to create targeted and durable Treg cell therapies aimed at curing these diseases. Their innovative approach is being validated through ongoing clinical trials, positioning them as leaders in the field of immune system restoration.
Something looks off?Open jobs at Sonoma BioTherapeutics
On-site & Remote
Seniority
Salary